tetrabenazine
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
70436-101 -
Package NDC
70436-101-09 -
Application number
ANDA213316 -
SPL ID
de4c0693-1b76-4026-bd94-a7a5dcc8a376 -
SPL set ID
49587379-1cc0-48ff-9f2f-517079cf499d -
UNII
Z9O08YRN8O -
RxCUI
199592 -
RxCUI
805464
What the source publishes
- Labeler
- Slate Run Pharmaceuticals, LLC
- Active ingredients
- tetrabenazine
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "tetrabenazine",
"splId": "de4c0693-1b76-4026-bd94-a7a5dcc8a376",
"labels": [
{
"setId": "49587379-1cc0-48ff-9f2f-517079cf499d",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49587379-1cc0-48ff-9f2f-517079cf499d",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=49587379-1cc0-48ff-9f2f-517079cf499d"
}
],
"routes": [
"ORAL"
],
"labeler": "Slate Run Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "112 TABLET in 1 BOTTLE (70436-101-09)",
"package_ndc": "70436-101-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20200302"
}
],
"productId": "70436-101_de4c0693-1b76-4026-bd94-a7a5dcc8a376",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "70436-101",
"deaSchedule": null,
"genericName": "tetrabenazine",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TETRABENAZINE",
"strength": "12.5 mg/1"
}
],
"applicationNumber": "ANDA213316",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20200302",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000190856",
"N0000190855"
],
"upc": [
"0370436102099",
"0370436101092"
],
"unii": [
"Z9O08YRN8O"
],
"rxcui": [
"199592",
"805464"
],
"spl_set_id": [
"49587379-1cc0-48ff-9f2f-517079cf499d"
],
"pharm_class_epc": [
"Vesicular Monoamine Transporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Vesicular Monoamine Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Slate Run Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:70436-101_de4c0693-1b76-4026-bd94-a7a5dcc8a376"